Objective-To study the antibiotic susceptibility of Neisseria gonorrhoeae strains isolated in Japan and, in particular, to 
10 jug/ml for norfloxacin; <0-016, 0-031-0-25, and >0.5,ug/ml for ofloxacin; <0-008, 0-016-0-063, and > 0-125 for ciprofloxacin. The MICs in the third category indicate reduced sensitivity.
Results

Antibiotic susceptibility
The MIC50, MIC90, and MIC ranges of the 15 tested antimicrobial agents against the 69 isolates from 1992 and the 27 isolates from 1981-84 are shown in table 1. Only 2 (2-9%) of the 69 strains from 1992 were /J-lactamaseproducing Neisseria gonorrhoeae (PPNG).
Therefore, for the studied penicillins the results of the non-PPNG strains were compared. The MIC90 value of norfloxacin against the isolates from 1992 was 20 0ug/ml, while that against the isolates from 1981-84 was 0-25 ug/ml. Therefore, the MIC90 value of norfloxacin against the isolates from 1992 was 8-fold higher than that against isolates from 1981-84. The MIC90 value of ofloxacin against the strains from 1992 (1 0,ug/ml) was also 8-fold higher than that against the strains from 1981-84 (0-125 ug/ml). Furthermore, the MIC90 value of ciprofloxacin against the strains from 1992 (0-5,ug/ml) was 8-fold higher than that against the strains from 1981-84 (0-063 ,ug/ml).
In general, the MIC90 values of the other tested antibiotics against the isolates from 1992 were equal, 2-fold higher, or 2-fold lower than those against the isolates from 1981-84.
The incidence of strains from 1992 with reduced sensitivity to norfloxacin (39-1%) was significantly higher than that of strains Our results demonstrated that there was significantly higher prevalence of reduced sensitivity to norfloxacin, ofloxacin, and ciprofloxacin among isolates from 1992, compared with isolates from 1981-84. The MIC90 values of norfloxacin, ofloxacin, and ciprofloxacin against the strains from 1992 were 2-0, 1-0, and 0 5,ug/ml, respectively, while those against the strains from 1981-84 were 0-25, 0-125, and 0-063 jg/ml, respectively. A decrease in susceptibility of gonococcal isolates to fluoroquinolones has also been observed in having MICs > 0-06 pg/ml treated with 800-mg single doses. In the present study, we measured the in vitro antimicrobial activity of fluoroquinolones against Neisseria gonorrhoeae, but did not evaluate the clinical efficacy of the agents. Because of the high prevalence of Neisseria gonorrhoeae isolates with low susceptibility to fluoroquinolones in Japan, it seems that single-dose treatment with these agents may be problematic as first-line therapy for gonorrhoea in our country. Therefore, the antimicrobial sensitivity of Neisseria gonorrhoeae to fluoroquinolones and the therapeutic efficacy of these antibiotics shoud be closely monitored.
Quinolone resistance in gram-negative bacteria involves alterations in DNA gyrase and the permeability of bacteria membranes. 18 Inactivation of quinolones by enzymatic degradation as a mechanism of bacterial resistance has not been reported, and plasmid-mediated resistance to quinolones has not been proved. The research on mechanisms of quinolone resistance in gonococci is very sparse. One study showed that reduced uptake in a ciprofloxacin-resistant strain of Neisseria gonorrhoeae could be a mechanism of gonococcal resistance to this agent.'9 However, the ciprofloxacin-resistant Neisseria gonorrhoeae tested in that study was only one strain. Further investigations of the mechanisms of quinolone resistance in Neisseria gonorrhoeae are indicated.
There were no significant differences in susceptibility to f-lactams, tetracyclines, macrolides, and spectinomycin between our isolates from 1992 and those from 1981-84. The incidence of PPNG (2.9%) in this study was lower than the incidence of 10% to 24% previously reported in Japan between 1983 and 1986.20 The observed low prevalence of PPNG may be associated with an increase in the use of fluoroquinolones for gonococcal infections in our country.
